Literature DB >> 12507916

Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Marie Magdeleine Ruchoux1, Valérie Domenga, Peggy Brulin, Jacqueline Maciazek, Sylvie Limol, Elisabeth Tournier-Lasserve, Anne Joutel.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an increasingly recognized adult-onset autosomal dominant vascular dementia, caused by highly stereotyped mutations in the Notch3 receptor. CADASIL is a widespread angiopathy characterized by a degeneration of vascular smooth muscle cells (VSMCs) and the abnormal accumulation of electron-dense granular material called GOM and Notch3 protein, because of an impaired clearance. Evidence that VSMCs are the primary target of the pathogenic process is supported by the restricted expression of Notch3 in these cells but mechanisms of their degeneration remain essentially unknown. We generated transgenic mice in which the SM22alpha promoter drove, in VSMCs, the expression of a full-length human Notch3 carrying the Arg90Cys mutation, a CADASIL archetypal mutation. Transgenic mice showed no evidence of prominent brain parenchyma damage but demonstrated the two hallmarks of the CADASIL angiopathy, GOM deposits and Notch3 accumulation, within both the cerebral and peripheral arteries. Of interest, arteries of the tail were more severely affected with prominent signs of VSMC degeneration. Time-course analysis of vessel changes revealed that disruption of normal VSMC anchorage to adjacent extracellular matrix and cells, VSMC cytoskeleton changes as well as starting signs of VSMC degeneration, which were detected around 10 months of age, preceded Notch3 and GOM accumulation appearance, which were observed only by 14 to 16 months of age. In conclusion, we have generated transgenic mice that recapitulate the characteristic vascular lesions observed in CADASIL. Our results indicate that Notch3 or GOM accumulation are unlikely to be the prerequisites for the induction of VSMC degeneration and suggest that degeneration of VSMCs may rather be triggered by the disruption of their normal anchorage, based on the important role of adhesion for cell survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507916      PMCID: PMC1851116          DOI: 10.1016/S0002-9440(10)63824-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  CADASIL: Notch signaling defect or protein accumulation problem?

Authors:  N B Spinner
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

3.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients.

Authors:  A Joutel; K Vahedi; C Corpechot; A Troesch; H Chabriat; C Vayssière; C Cruaud; J Maciazek; J Weissenbach; M G Bousser; J F Bach; E Tournier-Lasserve
Journal:  Lancet       Date:  1997-11-22       Impact factor: 79.321

4.  Endothelial changes in muscle and skin biopsies in patients with CADASIL.

Authors:  M M Ruchoux; C A Maurage
Journal:  Neuropathol Appl Neurobiol       Date:  1998-02       Impact factor: 8.090

5.  Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains.

Authors:  M Dichgans; H Ludwig; J Müller-Höcker; A Messerschmidt; T Gasser
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

6.  The natural history of CADASIL: a pooled analysis of previously published cases.

Authors:  D W Desmond; J T Moroney; T Lynch; S Chan; S S Chin; J P Mohr
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

7.  De novo mutation in the Notch3 gene causing CADASIL.

Authors:  A Joutel; D D Dodick; J E Parisi; M Cecillon; E Tournier-Lasserve; M G Bousser
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

8.  Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group.

Authors:  S A Oberstein; M D Ferrari; E Bakker; J van Gestel; A L Kneppers; R R Frants; M H Breuning; J Haan
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

9.  Patterns of MRI lesions in CADASIL.

Authors:  H Chabriat; C Levy; H Taillia; M T Iba-Zizen; K Vahedi; A Joutel; E Tournier-Lasserve; M G Bousser
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

10.  The phenotypic spectrum of CADASIL: clinical findings in 102 cases.

Authors:  M Dichgans; M Mayer; I Uttner; R Brüning; J Müller-Höcker; G Rungger; M Ebke; T Klockgether; T Gasser
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  56 in total

1.  Notch3 is required for arterial identity and maturation of vascular smooth muscle cells.

Authors:  Valérie Domenga; Peggy Fardoux; Pierre Lacombe; Marie Monet; Jacqueline Maciazek; Luke T Krebs; Bernard Klonjkowski; Eliane Berrou; Matthias Mericskay; Zhen Li; Elisabeth Tournier-Lasserve; Thomas Gridley; Anne Joutel
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

Review 2.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 3.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 4.  Cell-to-cell communication and vascular dementia.

Authors:  Hans H Dietrich
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

Review 5.  CADASIL: experimental insights from animal models.

Authors:  Cenk Ayata
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

6.  Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.

Authors:  Xiujie Li; Ezequiel Calvo; Marc Cool; Pavel Chrobak; Denis G Kay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 7.  Smooth muscle cell phenotypic switching in stroke.

Authors:  Marine Poittevin; Pierre Lozeron; Rose Hilal; Bernard I Levy; Tatiana Merkulova-Rainon; Nathalie Kubis
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

8.  Peri-arterial specification of vascular mural cells from naïve mesenchyme requires Notch signaling.

Authors:  Koji Ando; Weili Wang; Di Peng; Ayano Chiba; Anne K Lagendijk; Lindsey Barske; J Gage Crump; Didier Y R Stainier; Urban Lendahl; Katarzyna Koltowska; Benjamin M Hogan; Shigetomo Fukuhara; Naoki Mochizuki; Christer Betsholtz
Journal:  Development       Date:  2019-01-25       Impact factor: 6.868

9.  Functional analysis of a recurrent missense mutation in Notch3 in CADASIL.

Authors:  T Haritunians; T Chow; R P J De Lange; J T Nichols; D Ghavimi; N Dorrani; D M St Clair; G Weinmaster; C Schanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

10.  Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.

Authors:  Marie Monet-Leprêtre; Boris Bardot; Barbara Lemaire; Valérie Domenga; Ophélia Godin; Martin Dichgans; Elisabeth Tournier-Lasserve; Michel Cohen-Tannoudji; Hugues Chabriat; Anne Joutel
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.